Functional proteomics to dissect tyrosine kinase signalling pathways in cancer

Walter Kolch, Andrew Pitt

Research output: Contribution to journalReview article

Abstract

Advances in the generation and interpretation of proteomics data have spurred a transition from focusing on protein identification to functional analysis. Here we review recent proteomics results that have elucidated new aspects of the roles and regulation of signal transduction pathways in cancer using the epidermal growth factor receptor (EGFR), ERK and breakpoint cluster region (BCR)-ABL1 networks as examples. The emerging theme is to understand cancer signalling as networks of multiprotein machines which process information in a highly dynamic environment that is shaped by changing protein interactions and post-translational modifications (PTMs). Cancerous genetic mutations derange these protein networks in complex ways that are tractable by proteomics.
LanguageEnglish
Pages618-629
Number of pages12
JournalNature Reviews: Cancer
Volume10
Issue number9
DOIs
Publication statusPublished - Sep 2010

Fingerprint

Proteomics
Protein-Tyrosine Kinases
Neoplasms
Post Translational Protein Processing
Epidermal Growth Factor Receptor
Signal Transduction
Proteins
Mutation

Bibliographical note

Copyright © 2010, Springer Nature

Keywords

  • animals
  • humans
  • neoplasms
  • protein binding
  • post-translational protein processing
  • protein-tyrosine kinases
  • proteomics
  • signal transduction

Cite this

@article{3233c065fda84cc8ade6bc2991381cb6,
title = "Functional proteomics to dissect tyrosine kinase signalling pathways in cancer",
abstract = "Advances in the generation and interpretation of proteomics data have spurred a transition from focusing on protein identification to functional analysis. Here we review recent proteomics results that have elucidated new aspects of the roles and regulation of signal transduction pathways in cancer using the epidermal growth factor receptor (EGFR), ERK and breakpoint cluster region (BCR)-ABL1 networks as examples. The emerging theme is to understand cancer signalling as networks of multiprotein machines which process information in a highly dynamic environment that is shaped by changing protein interactions and post-translational modifications (PTMs). Cancerous genetic mutations derange these protein networks in complex ways that are tractable by proteomics.",
keywords = "animals, humans, neoplasms, protein binding, post-translational protein processing, protein-tyrosine kinases, proteomics, signal transduction",
author = "Walter Kolch and Andrew Pitt",
note = "Copyright {\circledC} 2010, Springer Nature",
year = "2010",
month = "9",
doi = "10.1038/nrc2900",
language = "English",
volume = "10",
pages = "618--629",
journal = "Nature Reviews: Cancer",
issn = "1474-175X",
publisher = "Nature Publishing Group",
number = "9",

}

Functional proteomics to dissect tyrosine kinase signalling pathways in cancer. / Kolch, Walter; Pitt, Andrew.

In: Nature Reviews: Cancer, Vol. 10, No. 9, 09.2010, p. 618-629.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Functional proteomics to dissect tyrosine kinase signalling pathways in cancer

AU - Kolch, Walter

AU - Pitt, Andrew

N1 - Copyright © 2010, Springer Nature

PY - 2010/9

Y1 - 2010/9

N2 - Advances in the generation and interpretation of proteomics data have spurred a transition from focusing on protein identification to functional analysis. Here we review recent proteomics results that have elucidated new aspects of the roles and regulation of signal transduction pathways in cancer using the epidermal growth factor receptor (EGFR), ERK and breakpoint cluster region (BCR)-ABL1 networks as examples. The emerging theme is to understand cancer signalling as networks of multiprotein machines which process information in a highly dynamic environment that is shaped by changing protein interactions and post-translational modifications (PTMs). Cancerous genetic mutations derange these protein networks in complex ways that are tractable by proteomics.

AB - Advances in the generation and interpretation of proteomics data have spurred a transition from focusing on protein identification to functional analysis. Here we review recent proteomics results that have elucidated new aspects of the roles and regulation of signal transduction pathways in cancer using the epidermal growth factor receptor (EGFR), ERK and breakpoint cluster region (BCR)-ABL1 networks as examples. The emerging theme is to understand cancer signalling as networks of multiprotein machines which process information in a highly dynamic environment that is shaped by changing protein interactions and post-translational modifications (PTMs). Cancerous genetic mutations derange these protein networks in complex ways that are tractable by proteomics.

KW - animals

KW - humans

KW - neoplasms

KW - protein binding

KW - post-translational protein processing

KW - protein-tyrosine kinases

KW - proteomics

KW - signal transduction

UR - http://www.scopus.com/inward/record.url?scp=77955942384&partnerID=8YFLogxK

U2 - 10.1038/nrc2900

DO - 10.1038/nrc2900

M3 - Review article

VL - 10

SP - 618

EP - 629

JO - Nature Reviews: Cancer

T2 - Nature Reviews: Cancer

JF - Nature Reviews: Cancer

SN - 1474-175X

IS - 9

ER -